Applied Dna Sciences Inc Net debt/EBITDA
Quel est le Net debt/EBITDA de Applied Dna Sciences Inc?
Le Net debt/EBITDA de Applied Dna Sciences Inc est 3.29
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Industrials secteur sur NASDAQ par rapport à Applied Dna Sciences Inc
Que fait Applied Dna Sciences Inc?
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Entreprises avec net debt/ebitda similaire à Applied Dna Sciences Inc
- MTU Aero Engines AG a Net debt/EBITDA de 3.28
- Evotec SE a Net debt/EBITDA de 3.28
- Rubius Therapeutics Inc a Net debt/EBITDA de 3.28
- Phreesia Inc a Net debt/EBITDA de 3.29
- S.A.S. Dragon a Net debt/EBITDA de 3.29
- Esco Technologies a Net debt/EBITDA de 3.29
- Applied Dna Sciences Inc a Net debt/EBITDA de 3.29
- Pelatro Plc a Net debt/EBITDA de 3.30
- Intuit a Net debt/EBITDA de 3.30
- Sunway International a Net debt/EBITDA de 3.30
- Exicure a Net debt/EBITDA de 3.30
- Exicure a Net debt/EBITDA de 3.30
- Exicure a Net debt/EBITDA de 3.30